Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 43,818 |
|
|||||
| News | - | ||||||
| Day High | 3.36 | Low High |
|||||
| Day Low | 2.8948 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celularity Inc | CELU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0836 | -2.72% | 2.9864 | 15:07:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.08 | 2.8948 | 3.36 | 3.07 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 616 | 43,818 | $ 3.16 | $ 138,548 | - | 1.59 - 8.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:02:57 | 80 | $ 2.995 | USD |
Celularity Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 222.19M | 21.78M | - | 17.98M | 14.19M | 0.65 | 15.66 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Celularity News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CELU Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.17 | 3.74 | 2.8948 | 3.11 | 68,661 | -0.1836 | -5.79% |
| 1 Month | 5.27 | 5.69 | 2.8948 | 4.02 | 50,581 | -2.28 | -43.33% |
| 3 Months | 4.881 | 7.97 | 2.8948 | 4.62 | 287,908 | -1.89 | -38.82% |
| 6 Months | 2.05 | 7.97 | 1.59 | 3.05 | 1,342,988 | 0.9364 | 45.68% |
| 1 Year | 6.459 | 8.90 | 1.59 | 3.54 | 1,017,334 | -3.47 | -53.76% |
| 3 Years | 107.191 | 134.00 | 1.59 | 17.77 | 631,495 | -104.20 | -97.21% |
| 5 Years | 107.191 | 134.00 | 1.59 | 17.77 | 631,495 | -104.20 | -97.21% |
Celularity Description
| Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. |
